Mapfre SA engaged in insurance activity in its various lines of business, both life and non-life, finance, securities investment, and services... Show more
MPFRY saw its Momentum Indicator move above the 0 level on July 31, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator turned positive. In of the 45 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for MPFRY just turned positive on August 11, 2025. Looking at past instances where MPFRY's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 167 cases where MPFRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
MPFRY broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 42, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.331) is normal, around the industry mean (1.945). P/E Ratio (11.272) is within average values for comparable stocks, (14.427). MPFRY's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.521). Dividend Yield (0.039) settles around the average of (0.044) among similar stocks. P/S Ratio (0.463) is also within normal values, averaging (1.548).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MPFRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
Industry MultiLineInsurance
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IHE | 69.67 | 0.57 | +0.82% |
iShares US Pharmaceuticals ETF | |||
AIFD | 32.47 | 0.03 | +0.09% |
TCW Artificial Intelligence ETF | |||
CEF | 30.99 | 0.01 | +0.03% |
Sprott Physical Gold and Silver Trust | |||
UCIB | 26.44 | -0.01 | -0.06% |
UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB | |||
AESR | 19.68 | -0.02 | -0.12% |
Anfield US Equity Sector Rotation ETF |
A.I.dvisor tells us that MPFRY and NNGRY have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MPFRY and NNGRY's prices will move in lockstep.
Ticker / NAME | Correlation To MPFRY | 1D Price Change % | ||
---|---|---|---|---|
MPFRY | 100% | N/A | ||
NNGRY - MPFRY | 4% Poorly correlated | -0.75% | ||
NNGPF - MPFRY | 2% Poorly correlated | N/A | ||
SAXPY - MPFRY | -1% Poorly correlated | +0.61% | ||
SAXPF - MPFRY | -2% Poorly correlated | +6.46% | ||
TNXXF - MPFRY | -2% Poorly correlated | N/A | ||
More |